Colorectal cancer
635 results
101 - 200
Anti-angiogenic therapies for metastatic colorectal cancer 
Symptoms not reliable in diagnosing colorectal cancer- Aspirin = screening to prevent colorectal cancer mortality
- Chemotherapy for advanced or metastatic colorectal cancer (2)
- USPSTF 2016: updated recommendations for colorectal cancer screening
Palliative chemotherapy for advanced or metastatic colorectal cancer- Screening and prevention of colorectal cancer
- Perioperative blood transfusions and recurrence of colorectal cancer
- Fecal immunochemical testing accurate for colorectal cancer screening
- Long-term results of laparoscopic colorectal cancer resection
- American Gastroenterological Association position statements for colorectal cancer screening
- Flex sig reduces incidence and mortality of colorectal cancer
- Nonadvanced colon adenoma may not increase colorectal cancer risk
- Colorectal cancer risk is increased in first-degree relatives
- SR: BRCA mutations are not associated with colorectal cancer
- Colorectal cancer screening modalities: variable uptake, variable yield (SAVE)
- Blood CEA levels for detecting recurrent colorectal cancer
- Second-line chemotherapy in advanced and metastatic colorectal cancer
- Long‐term results of laparoscopic colorectal cancer resection
- Herbal medicines for advanced colorectal cancer: Cochrane systematic review
- Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps
- Anti‐angiogenic therapies for metastatic colorectal cancer
- Selective internal radiation therapy for liver metastases from colorectal cancer
- Erythropoeitin for reducing allogeneic blood transfusions in colorectal cancer surgery
- Screening for colorectal cancer using the faecal occult blood test, Hemoccult
- USPSTF: Some adults should take aspirin to prevent CVD, colorectal cancer
- Follow-up strategies for patients treated for non-metastatic colorectal cancer
- Duration of adjuvant chemotherapy for patients with non-metastatic colorectal cancer
- Accuracy of fecal DNA and fecal immunochemical test for colorectal cancer detection
- Workload and surgeon´s specialty for outcome after colorectal cancer surgery
- No increased survival benefit to intensive follow-up after colorectal cancer surgery
- High adenoma detection rate during colonoscopy associated with lower incidence of colorectal cancer
- Follow‐up strategies for patients treated for non‐metastatic colorectal cancer
- Mailing FIT or gFOBT directly to patients increases uptake of colorectal cancer screening
- Histamine type 2 receptor antagonists as adjuvant treatment for resected colorectal cancer
- Second-line systemic therapy for metastatic colorectal cancer: Cochrane systematic review
- Oral versus intravenous fluoropyrimidines for colorectal cancer